Spots Global Cancer Trial Database for niraparib plus anlotinib
Every month we try and update this database with for niraparib plus anlotinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer | NCT05311579 | Ovarian Carcino... Survival Outcom... Adverse Events Niraparib Anlotinib CA125 Chemotherapy Targeted Therap... Recurrent Ovari... | Niraparib plus ... | 18 Years - | Peking Union Medical College Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
